Appointment Details
Lupin Limited announced the appointment of Brian Savage as President and Chief Legal Officer, effective October 23, 2026. In this role, Savage will lead Lupin's global Legal, Compliance, and Intellectual Property Management Group (IPMG) functions. He will be based in New Jersey, USA.
Professional Background
Brian Savage joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015. His most recent position at Teva was Executive Vice President and Interim Global Chief Legal Officer. During his tenure at Teva, he also led the company's global litigation strategy and served as General Counsel for its U.S. Generics business. Prior to joining Teva, Savage practiced law at Dechert LLP.
Educational Qualifications
Savage holds a Juris Doctor (J.D.) from Yale Law School and a B.A., summa cum laude, from the University of Pennsylvania.
Management Commentary
Lupin CEO Vinita Gupta and Managing Director Nilesh Gupta commented on the appointment, stating: "We are delighted to welcome Brian to our executive leadership team. His deep understanding of the pharmaceutical industry landscape, extensive legal expertise, and proven leadership will be valuable as we continue to strengthen our governance framework, navigate an evolving regulatory environment, and advance our long term growth ambitions."
Disclosure Submission
The disclosure was submitted to both National Stock Exchange of India Limited and BSE Limited by Amit Kumar Gupta, Company Secretary & Compliance Officer (ACS -15754) of Lupin Limited on October 23, 2026 at 09:51:19 IST.